Skip to main content
ODYY logo

ODYY · Odyssey Health, Inc.

Track ODYY — free
$0.01 0.00 (-2.02%) At close · Sep 1
Market Cap
$1.01M
Shares
100.97M

ODYY metrics

46 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.01
Market cap
$1.01M

Price action

19 metrics
Price change (1W)
-3.0%
Price change (30D)
-1.0%
Price change (3M)
-30.7%
Price change (6M)
-83.3%
Price change (YTD)
-70.6%
Price change (1Y)
-88.7%
Trailing year
Price change (5Y)
-97.6%
52-week high
$0.11
52-week low
$0.00
Change from 52-week high
-90.8%
Change from 52-week low
+142.5%
Annualized volatility
263.0%
Beta
2.6
RSI (14D)
53.2
Price vs SMA 50
+19.0%
Price vs SMA 200
-78.3%
Avg volume (3M)
231,934
Relative volume
0.8
Average dollar volume
$1,996

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
100.97M

Valuation

12 metrics
P / E (TTM)
Trailing earnings
PEG ratio
EV / revenue
EV / EBITDA
EV / EBIT
P / sales
P / book
FCF yield
TTM · current market cap
Buyback yield
P / FCF
P / operating cash flow
Earnings yield
-353.7%

Historical valuation

8 metrics
P / E historical average (3Y)
P / E historical average (5Y)
EV / revenue historical average (3Y)
EV / revenue historical average (5Y)
EV / EBIT historical average (3Y)
EV / EBIT historical average (5Y)
EV / EBITDA historical average (3Y)
EV / EBITDA historical average (5Y)

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings

Profitability

9 metrics
Gross margin
Operating margin
Trailing 12 months
Net margin
Gross profit (TTM)
$0
Operating profit (TTM)
−$938,364
Net income (TTM)
−$3.57M
Trailing 12 months
Diluted EPS (TTM)
$-0.03
FCF margin
Effective tax rate

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share
$-0.01

Growth

11 metrics
Revenue growth YoY
Year over year
Net income growth YoY
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
Shares change YoY
+78.3%
Year over year · more shares
Revenue CAGR (3Y)
Revenue CAGR (5Y)
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
FCF CAGR (5Y)

Quality

14 metrics
Return on equity
Return on assets
-955.4%
Debt / equity
Current ratio
0.0
EBITDA (TTM)
−$1.13M
Free cash flow (TTM)
Quick ratio
0.0
Interest coverage
-0.9
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Cash & equivalents
$297,806
Total assets
$373,779
Total debt

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$934,977
Capital expenditures (TTM)
R&D (TTM)
$0
SG&A (TTM)
Stock compensation (TTM)
$0
R&D / revenue
Stock compensation / revenue

Ownership (13F)

3 metrics
13F filers
13F filer change QoQ
Institutional ownership

Short interest

3 metrics
Short interest
0.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
46 / 100

Insider activity

2 metrics
Net insider buying (90D)
Insider-sentiment score

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1626644 CUSIP 67612C102 Visit website Investor relations